BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9197495)

  • 1. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.
    Gale N; Zidar N; Kambic V; Poljak M; Cör A
    Acta Otolaryngol Suppl; 1997; 527():105-10. PubMed ID: 9197495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomes 7,17 polysomies and overexpression of epidermal growth factor receptor and p53 protein in epithelial hyperplastic laryngeal lesions.
    Gale N; Kambic V; Poljak M; Cör A; Velkavrh D; Mlacak B
    Oncology; 2000 Feb; 58(2):117-25. PubMed ID: 10705238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus infection and expression of p53 and c-erbB-2 protein in laryngeal papillomas.
    Luzar B; Gale N; Kambic V; Poljak M; Zidar N; Vodovnik A
    Acta Otolaryngol Suppl; 1997; 527():120-4. PubMed ID: 9197499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ER-D5 and EGFr in laryngeal carcinoma and pre-malignant epithelium.
    Maiorano E; Botticella MA; Marzullo A; Resta L
    Acta Otolaryngol Suppl; 1997; 527():95-9. PubMed ID: 9197492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biopathology of metaplastic, dysplastic, and neoplastic laryngeal epithelium.
    Resta L; Marsigliante S; Leo G; Fiorella R; Di Nicola V; Maiorano E
    Acta Otolaryngol Suppl; 1997; 527():39-42. PubMed ID: 9197478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of p53 protein in benign and malignant laryngeal epithelial lesions.
    Poljak M; Gale N; Kambic V; Ferluga D; Fischinger J
    Anticancer Res; 1996; 16(4A):1947-51. PubMed ID: 8712726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of epidermal growth factor receptor in laryngeal squamous cell carcinomas.
    Christensen ME; Therkildsen MH; Hansen BL; Hansen GN; Bretlau P
    Acta Otolaryngol; 1992; 112(4):734-8. PubMed ID: 1442018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperplastic lesions of the larynx. Experience of the Barcelona group.
    Cardesa A; Nadal A; Jares P; Mallofré C; Fernández PL; Campo E; Traserra J
    Acta Otolaryngol Suppl; 1997; 527():43-6. PubMed ID: 9197479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The supplementary diagnostic power of selected immunohistochemical, molecular genetic and infective parameters in epithelial hyperplastic laryngeal lesions.
    Kleist B; Junghans D; Lorenz G; Bankau A; Poetsch M
    Oncology; 2003; 65(4):347-54. PubMed ID: 14707455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
    Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
    Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
    Zidar N; Gale N; Cör A; Kambic V
    J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of EGF, EGFR and PCNA in laryngeal lesions.
    Wen QH; Nishimura T; Miwa T; Nagayama I; Furukawa M
    J Laryngol Otol; 1995 Jul; 109(7):630-6. PubMed ID: 7561470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Ljubljana classification of epithelial hyperplastic laryngeal lesions: a morphometric evaluation of nuclear pleomorphism].
    Serio G; Gale N; Pennella A; Dalena AM; Giardina C; Valente T; Lettini T; Ricco R; Resta L
    Pathologica; 2002 Dec; 94(6):290-8. PubMed ID: 12540992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
    Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
    Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Lublańska classification of precancerous lesions of the larynx].
    Golusiński W; Kaczmarek JP; Kaczmarek J; Biczysko W; Kedzia D
    Otolaryngol Pol; 2001; 55(1):69-73. PubMed ID: 11355482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology.
    Hellquist H; Cardesa A; Gale N; Kambic V; Michaels L
    Histopathology; 1999 Mar; 34(3):226-33. PubMed ID: 10217563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions.
    Gale N; Kambic V; Michaels L; Cardesa A; Hellquist H; Zidar N; Poljak M
    Adv Anat Pathol; 2000 Jul; 7(4):240-51. PubMed ID: 10907809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of p27 is correlated with progression in precancerous lesions of the larynx.
    Hirai T; Hayashi K; Takumida M; Ueda T; Hirakawa K; Yajin K
    Auris Nasus Larynx; 2003 May; 30(2):163-8. PubMed ID: 12753988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors.
    Khademi B; Shirazi FM; Vasei M; Doroudchi M; Gandomi B; Modjtahedi H; Pezeshki AM; Ghaderi A
    Cancer Lett; 2002 Oct; 184(2):223-30. PubMed ID: 12127695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects in the pathology of the preneoplastic lesions of the larynx.
    Sugár J; Vereczkey I; Tóth J; Péter I; Bánhidy F
    Acta Otolaryngol Suppl; 1997; 527():52-6. PubMed ID: 9197482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.